Reply by Authors
J Urol
.
2023 Aug;210(2):279-280.
doi: 10.1097/JU.0000000000003549.02.
Epub 2023 Aug 1.
Authors
Stephen W Reese
1
,
Sari Khaleel
1
,
Andrew Silagy
1
,
Amy Xie
2
,
Lennert Eismann
1
3
,
Katiana Vazquez-Rivera
1
,
Arnold Oparanozie
1
,
Sujata Patil
4
,
Jonathan Coleman
1
,
Robert Motzer
5
,
Ritesh R Kotecha
5
,
Paul Russo
1
,
Martin H Voss
5
,
A Ari Hakimi
1
Affiliations
1
Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
2
Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
3
Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio.
4
Department of Urology, Ludwig-Maximilians University, Munich, Germany.
5
Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
PMID:
37416962
DOI:
10.1097/JU.0000000000003549.02
No abstract available